DLRC Group

DLRC Group

Munich, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

DLRC Group is a private, revenue-generating services firm formed through the acquisition and expansion of established regulatory consultancies. Founded in 2023 as a holding entity, it consolidates the UK-based DLRC Ltd (founded 2005), Germany's Orphix Consulting GmbH (acquired 2020), and the newly established US office, DLRC Inc. (2023). The group offers a seamless, single-point-of-contact service model, providing expert regulatory strategy and submission support for diagnostics and medical device companies across major global markets. Its value proposition is built on decades of collective experience, multilingual teams, and close relationships with regulatory agencies.

DiagnosticsMedical Devices

Technology Platform

Intellectual capital and service platform for global regulatory strategy, submissions, and representative services for diagnostics and medical devices.

Opportunities

Significant demand driven by the complex implementation of the EU MDR/IVDR regulations and the trend for medical device/diagnostic companies to seek global market access simultaneously.
The group's established EU and new US presence positions it to capture this cross-border regulatory strategy work.

Risk Factors

Revenue is susceptible to fluctuations in regulatory submission cycles and potential saturation of the EU MDR/IVDR consulting market.
The business is highly reliant on the reputation and retention of its key regulatory experts and founders.

Competitive Landscape

Competes with large, full-service CROs (like IQVIA, Parexel) that have regulatory divisions, as well as numerous small-to-midsize specialist regulatory consultancies. Differentiation is based on deep sector focus (diagnostics/devices), personalized service, and integrated global coverage through a single contact.